Paris, September 16 2021: Medicus AI, the platform that automates the interpretation of medical reports, is pleased to announce that it is now live in France with LABEXA (EXALAB, LBA, SEALAB), the number one independent medical laboratory group in the Nouvelle-Aquitaine region.

With this production launch, LABEXA strengthens its position and confirms its desire to be part of the technological movement that is revolutionizing biomedicine in France. From now on, more than three million patients will have direct access to new test results.

Jean-Philippe GALHAUD, Director of Medical Affairs, LABEXA Group:

“The digital revolution is underway. Health and biomedicine are high-tech fields that are already being disrupted by innovations. Our partnership with Medicus allows us to assert our major role as a stakeholder in healthcare. Through technology, we get closer to our patients and prescribers by delivering clear and personalized medical insights.”

Jules CAPUT, Project Manager, MEDICUS AI :

“We are very proud that we could support and implement this project in collaboration with the LABEXA group. Three million patients can now better understand their health and make well-informed decisions.”